Talcum Powder Asbestos Lawsuit Results in $325M Verdict Against Johnson & Johnson

|

After a New York jury initially awarded $25 million in compensatory damages to a woman diagnosed with mesothelioma, Johnson & Johnson has been hit with an additional $300 million in punitive damages, which are designed to punish the company for withholding information about the risks associated with asbestos in talcum powder products, including Johnson’s Baby Powder and Shower-to-Shower.

The verdict comes in the second phase of a trial in the New York City Asbestos Litigation (NYCAL) court, involving claims brought by Donna Olson, which was the first of four talcum powder asbestos cases that are expected to be tried in the court this year.

The combined judgment of $325 million marks the first time since the 1980s that New York’s “asbestos court” has handed out punitive damages, which are generally rare and reserved for particularly reprehensible conduct.

|
|

Olson established for the jury that she developed mesothelioma from asbestos contained in talc particles, which she regularly breathed while applying the Johnson & Johnson products from the time she was about eight years old, until at least 1984.

Mesothelioma is a rare form of cancer that is only known to occur as a result of exposure to asbestos. It typically has a very long latency period before it is diagnosed, and the disease is often at a very advanced stage by the time it is discovered, resulting in few treatment options.

Johnson & Johnson indicates that it plans to appeal the verdict, and has refused to negotiate talcum powder settlements, despite a number of similar verdicts returned in recent years for women diagnosed with mesothelioma and ovarian cancer following regular use of the company’s talc-based products.

Failure to Warn Lawsuits Over Talcum Powder

Johnson & Johnson currently faces nearly 12,000 Johnson’s Baby Powder lawsuits and Shower-to-Shower lawsuits pending in courts nationwide, each raising similar claims that the manufacturer has known for decades about the potential link between talc powder and cancer, yet failed to warn consumers.

In addition to mesothelioma claims, many of the complaints involve allegations that particles included in the talcum powder may cause ovarian cancer, following years of regular application around the genitals for feminine hygiene, which has been marketed by the company for decades.

A number of cases have already gone to trial at the state level, with several resulting in large verdicts for plaintiffs, often including punitive damages. Last year, a Missouri jury returned a landmark $4.7 billion verdict for 22 women diagnosed with ovarian cancer.

Most of the talcum powder litigation is current pending in the federal court system, where lawsuits filed by individuals nationwide are centralized for pretrial proceedings as part of a multidistrict litigation (MDL), which is centralized before U.S. District Judge Freda L. Wolfson in the District of New Jersey.

Later this year, Judge Wolfson is expected to rule on Johnson & Johnson’s challenges to the admissibility of certain expert witness testimony under the federal rules. However, if the Court finds that the evidence is sufficiently reliable, Johnson & Johnson could face large numbers of individual trial dates in courts nationwide in coming years.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.
A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL.
Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation.